118 related articles for article (PubMed ID: 37018994)
21. DT-13 synergistically enhanced vinorelbine-mediated mitotic arrest through inhibition of FOXM1-BICD2 axis in non-small-cell lung cancer cells.
Li H; Sun L; Li H; Lv X; Semukunzi H; Li R; Yu J; Yuan S; Lin S
Cell Death Dis; 2017 May; 8(5):e2810. PubMed ID: 28542137
[TBL] [Abstract][Full Text] [Related]
22. Tanshinone IIA combined with adriamycin inhibited malignant biological behaviors of NSCLC A549 cell line in a synergistic way.
Xie J; Liu JH; Liu H; Liao XZ; Chen Y; Lin MG; Gu YY; Liu TL; Wang DM; Ge H; Mo SL
BMC Cancer; 2016 Nov; 16(1):899. PubMed ID: 27863471
[TBL] [Abstract][Full Text] [Related]
23. [The effect and mechanism of vinorelbine on cisplatin resistance of human lung cancer cell line A549/DDP].
Qi C; Gao S; Li H; Gao W
Zhongguo Fei Ai Za Zhi; 2014 Feb; 17(2):148-54. PubMed ID: 24581167
[TBL] [Abstract][Full Text] [Related]
24. Bystander effect of vinorelbine alters antitumor immune response.
Thomas-Schoemann A; Lemare F; Mongaret C; Bermudez E; Chéreau C; Nicco C; Dauphin A; Weill B; Goldwasser F; Batteux F; Alexandre J
Int J Cancer; 2011 Sep; 129(6):1511-8. PubMed ID: 21128224
[TBL] [Abstract][Full Text] [Related]
25. Paclitaxel and vinorelbine cause synergistic increases in apoptosis but not in microtubular disruption in human lung adenocarcinoma cells (A-549).
Jung M; Grunberg S; Timblin C; Buder-Hoffman S; Vacek P; Taatjes DJ; Mossman BT
Histochem Cell Biol; 2004 Feb; 121(2):115-21. PubMed ID: 14745558
[TBL] [Abstract][Full Text] [Related]
26. Defining the molecular signature of chemotherapy-mediated lung tumor phenotype modulation and increased susceptibility to T-cell killing.
Gameiro SR; Caballero JA; Hodge JW
Cancer Biother Radiopharm; 2012 Feb; 27(1):23-35. PubMed ID: 22316209
[TBL] [Abstract][Full Text] [Related]
27. Enhancing effect of connexin 32 gene on vinorelbine-induced cytotoxicity in A549 lung adenocarcinoma cells.
Sato H; Fukumoto K; Hada S; Hagiwara H; Fujimoto E; Negishi E; Ueno K; Yano T
Cancer Chemother Pharmacol; 2007 Aug; 60(3):449-57. PubMed ID: 17569045
[TBL] [Abstract][Full Text] [Related]
28. Gemcitabine and vinorelbine in patients with advanced lung cancer: preclinical studies and report of a phase I trial.
Herbst RS; Lynch C; Vasconcelles M; Teicher BA; Strauss G; Elias A; Anderson I; Zacarola P; Dang NH; Leong T; Salgia R; Skarin AT
Cancer Chemother Pharmacol; 2001 Aug; 48(2):151-9. PubMed ID: 11561781
[TBL] [Abstract][Full Text] [Related]
29. T-cell levels and response to thymosin in vitro during intensive chemotherapy in cancer patients receiving thymosin.
Goldberg NH; Lipson SD; Kenady DE; Simon RM; Cohen MH; Chretien PB
Surg Forum; 1977; 28():151-2. PubMed ID: 214880
[No Abstract] [Full Text] [Related]
30. Preclinical studies with IRX-2 and thymosin alpha1 in combination therapy.
Naylor PH; Hadden JW
Ann N Y Acad Sci; 2010 Apr; 1194():162-8. PubMed ID: 20536465
[TBL] [Abstract][Full Text] [Related]
31. Anti-tubulin agent vinorelbine inhibits metastasis of cancer cells by regulating epithelial-mesenchymal transition.
Liu H; Fu Q; Lu Y; Zhang W; Yu P; Liu Z; Sun X
Eur J Med Chem; 2020 Aug; 200():112332. PubMed ID: 32473523
[TBL] [Abstract][Full Text] [Related]
32. Enhanced antitumor and anti-angiogenic effects of metronomic Vinorelbine combined with Endostar on Lewis lung carcinoma.
Qin RS; Zhang ZH; Zhu NP; Chen F; Guo Q; Hu HW; Fu SZ; Liu SS; Chen Y; Fan J; Han YW
BMC Cancer; 2018 Oct; 18(1):967. PubMed ID: 30305062
[TBL] [Abstract][Full Text] [Related]
33. [Effect of thymosin alpha 1 on cellular immune function in elderly patients with malignant tumor].
Yang YM; Lu XY; Huang WD; Shen MY
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2003 Aug; 32(4):339-41. PubMed ID: 12970939
[TBL] [Abstract][Full Text] [Related]
34. Thymosin in cancer patients: in vitro effects and correlations with clinical response to thymosin immunotherapy.
Chretien PB; Lipson SD; Makuch R; Kenady DE; Cohen MH; Minna JD
Cancer Treat Rep; 1978 Nov; 62(11):1787-90. PubMed ID: 215307
[TBL] [Abstract][Full Text] [Related]
35. Thymosin β10 promotes tumor-associated macrophages M2 conversion and proliferation via the PI3K/Akt pathway in lung adenocarcinoma.
Zeng J; Yang X; Yang L; Li W; Zheng Y
Respir Res; 2020 Dec; 21(1):328. PubMed ID: 33349268
[TBL] [Abstract][Full Text] [Related]
36. Multidrug resistance-associated protein 3 and Bcl-2 contribute to multidrug resistance by vinorelbine in lung adenocarcinoma.
Hong X; Yang ZY; Wang M; Lu L; Li YH; Hao X; Chen GY
Int J Mol Med; 2011 Dec; 28(6):953-60. PubMed ID: 21874222
[TBL] [Abstract][Full Text] [Related]
37. Synergistic effects of combining proteasome inhibitors with chemotherapeutic drugs in lung cancer cells.
Sooman L; Gullbo J; Bergqvist M; Bergström S; Lennartsson J; Ekman S
BMC Res Notes; 2017 Nov; 10(1):544. PubMed ID: 29096687
[TBL] [Abstract][Full Text] [Related]
38. Sodium valproate, a histone deacetylase inhibitor, enhances the efficacy of vinorelbine-cisplatin-based chemoradiation in non-small cell lung cancer cells.
Gavrilov V; Lavrenkov K; Ariad S; Shany S
Anticancer Res; 2014 Nov; 34(11):6565-72. PubMed ID: 25368259
[TBL] [Abstract][Full Text] [Related]
39. Cisplatin and Vinorelbine -Mediated Electrochemotherapeutic Approach Against Multidrug Resistant Small Cell Lung Cancer (H69AR)
Drąg-Zalesińska M; Saczko J; Choromańska A; Szewczyk A; Rembiałkowska N; Kulbacka J; Rzechonek A
Anticancer Res; 2019 Jul; 39(7):3711-3718. PubMed ID: 31262897
[TBL] [Abstract][Full Text] [Related]
40. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
Clegg A; Scott DA; Sidhu M; Hewitson P; Waugh N
Health Technol Assess; 2001; 5(32):1-195. PubMed ID: 12065068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]